{"id":6260,"date":"2026-06-29T12:47:17","date_gmt":"2026-06-29T12:47:17","guid":{"rendered":"https:\/\/www.dentulu.com\/blog\/?p=6260"},"modified":"2026-06-29T12:50:20","modified_gmt":"2026-06-29T12:50:20","slug":"the-dawn-of-dentistry-3-0-key-takeaways-from-the-2026-ada-adso-chicago-summits","status":"publish","type":"post","link":"https:\/\/www.dentulu.com\/blog\/the-dawn-of-dentistry-3-0-key-takeaways-from-the-2026-ada-adso-chicago-summits\/","title":{"rendered":"The Dawn of Dentistry 3.0: Key Takeaways from the 2026 ADA & ADSO Chicago Summits"},"content":{"rendered":"

The boundaries between oral health, systemic medicine, and cutting-edge business infrastructure are officially vanishing. This June, Chicago became the epicenter of the dental universe, hosting two monumental, back-to-back industry events: the American Dental Association (ADA) Salivary Diagnostics Summit and the 15th annual Association of Dental Support Organizations (ADSO) Summit.<\/span><\/p>\n

Together, these premier events outlined a profound shift in the industry: moving rapidly away from reactive, siloed treatments and marching toward a collaborative, tech-driven, and highly preventive future.<\/span><\/p>\n

Among the prominent thought leaders driving this conversation was <\/span>Dr. Arash Hakhamian<\/span><\/a>, CEO of<\/span> Dentulu.<\/span><\/a> He took the stage in Chicago to share a visionary blueprint for what he defines as “Dentistry 3.0”: A future where clinical innovation, advanced biotechnology, and strong executive leadership unite to fundamentally transform patient care.<\/span><\/p>\n

For dental professionals, executives, and patients alike, here are the major highlights from Chicago that are set to redefine the next 15 years of dental medicine.<\/span><\/p>\n

    \n
  1. Saliva as the Ultimate Diagnostic Mirror<\/b><\/li>\n<\/ol>\n

    For generations, routine dental checkups have relied almost exclusively on visual inspections and digital X-rays. While effective for spotting cavities, periodontal pockets, or bone loss that has already occurred, these methods are inherently reactive.<\/span><\/p>\n

    The central theme of the ADA summit was the revolutionary power of salivary diagnostics. Saliva is no longer viewed merely as a digestive fluid; it is a bio-fluid goldmine. It contains critical proteins, DNA, RNA, and microbial biomes that directly mirror what is happening inside the entire human body.<\/span><\/p>\n

    Dr. Arash highlighted how analyzing these specific salivary biomarkers allows modern clinicians to detect early signs of periodontal disease, oral cancers, and even systemic markers related to diabetes, inflammation, and cardiovascular health. By screening <\/span>saliva<\/span><\/a>, dentists can identify a patient’s genetic and microbiological risks before clinical symptoms physically manifest.<\/span><\/p>\n

      \n
    1. Transitioning to “Dentistry 3.0”<\/b><\/li>\n<\/ol>\n

      One of the most talked-about presentations of the event was Dr. Arash’s breakdown of the evolution of modern dental medicine, challenging the industry to step into the next phase:<\/span><\/p>\n